Corxel Plans Public Listing with Focus on GLP-1 and Amylin Obesity Drugs | Retatrutide News

Corxel is going public via a SPAC deal, focusing on GLP-1 and amylin-targeting obesity drugs. This move highlights the growing interest in GLP-1 recepto...
Market News · October 27, 2026